Transcatheter Arterial Embolization for Elbow and Foot Plantar Pain

Launched by CHUNG-ANG UNIVERSITY HOSPTIAL, CHUNG-ANG UNIVERSITY COLLEGE OF MEDICINE · Jul 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a procedure called transcatheter arterial embolization (TAE) to help people with chronic pain in the elbow or foot caused by conditions like lateral epicondylitis (tennis elbow) or plantar fasciitis. The trial is looking for patients who have been experiencing moderate to severe pain for more than six months and have tried other treatments like physical therapy or pain medications without relief. Participants will be monitored for changes in their pain levels at 6 and 12 months after the procedure.

To be eligible for the trial, patients need to have confirmed signs of increased blood flow (hypervascularization) in the painful area through imaging tests like ultrasound or MRI. Patients should also be at least 18 years old and not pregnant or breastfeeding. Those with local infections or bleeding disorders are not eligible. If you decide to join the trial, you'll be part of an important study aiming to find better treatments for ongoing pain in the elbow or foot.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who voluntarily signed a written consent form after receiving an explanation of the purpose, method, and effects of this clinical trial
• • Patients who have had pain in the relevant area for more than 6 months and have a history of receiving physical therapy, analgesic anti-inflammatory medication, or local injection treatment
• • Patients in whom hypervascularization was confirmed in the relevant area through imaging results (US, CT, MRI) evaluating the cause of pain.
• Exclusion Criteria:
• • Patients are pregnant or breastfeeding
• • Local infection in the painful area
• • Patients have a bleeding disease